ESSA Pharma Inc EPIX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
6.88quote price arrow down-0.07 (-1.01%)
Volume
13,244
52 week range
2.56 - 11.67
Loading...
  • Open7.03
  • Day High7.33
  • Day Low6.74
  • Prev Close6.95
  • 52 Week High11.67
  • 52 Week High Date02/07/24
  • 52 Week Low2.56
  • 52 Week Low Date05/03/23

Key Stats

  • Market Cap304.358M
  • Shares Out44.24M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change4.24

KEY STATS

  • Open7.03
  • Day High7.33
  • Day Low6.74
  • Prev Close6.95
  • 52 Week High11.67
  • 52 Week High Date02/07/24
  • 52 Week Low2.56
  • 52 Week Low Date05/03/23
  • Market Cap304.358M
  • Shares Out44.24M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change4.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.59
  • P/E (TTM)-11.76
  • Fwd P/E (NTM)-6.44
  • EBITDA (TTM)-31.87M
  • ROE (TTM)-17.05%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ESSA Pharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer...
Richard Glickman LL.D.
Non-Executive Independent Chairman of the Board
David Parkinson M.D.
President, Chief Executive Officer, Director
Peter Virsik
Chief Operating Officer, Executive Vice President
David Wood CPA
Chief Financial Officer
Alessandra Cesano M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Address
999 West Broadway, Suite 720
Vancouver, BC
V5Z 1K5
Canada

Top Peers

SYMBOLLASTCHG%CHG
CYBN
Cybin Inc
0.35UNCHUNCH
MDNA
Medicenna Therapeutics Corp
2.39+0.01+0.42%
CRDL
Cardiol Therapeutics Inc
1.99+0.01+0.51%
ZOM
Zomedica Corp
0.1452+0.0032+2.2535%
SVA
Sinovac Biotech Ltd
6.47UNCHUNCH